Suppression of tumorigenicity in neuroblastoma cells by upregulatior of human vasoactive intestinal peptide receptor type 1BALSTER, Douglas A; O'DORISIO, M. Sue; ALBERS, Anne R et al.Regulatory peptides. 2002, Vol 109, Num 1-3, pp 155-165, issn 0167-0115, 11 p.Conference Paper

Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas : Implications for tumor biology and potential clinical utilityFRÜHWALD, Michael C; O'DORISIO, M. Sue; ZUNYAN DAI et al.Oncogene (Basingstoke). 2001, Vol 20, Num 36, pp 5033-5042, issn 0950-9232Article

Development of a novel in vitro human tissue-based angiogenesis assay to evaluate the effect of antiangiogenic drugsWOLTERING, Eugene A; LEWIS, James M; THOMPSON, James C et al.Annals of surgery. 2003, Vol 237, Num 6, pp 790-800, issn 0003-4932, 11 p.Conference Paper

Development of a human cardiac tissue-based angiogenesis modelLEWIS, James M; ANTHONY, Catherine T; HARRISON, Lynn H et al.The Journal of surgical research. 2006, Vol 135, Num 1, pp 34-37, issn 0022-4804, 4 p.Article

Segmental expression of somatostatin receptor subtypes sst₁ and sst₂ in tubules and glomeruli of human kidneyBALSTER, Douglas A; O'DORISIO, M. S. U. E; SUMMERS, Monica A et al.American journal of physiology. Renal physiology. 2001, Vol 49, Num 3, pp F457-F465, issn 1931-857XArticle